The evolution of stereo-electroencephalography (SEEG) has transformed epilepsy treatment by offering deeper insights into seizure foci localization and seizure networks.
Resuming of direct sales in the U.S. market starting in Q4 2025
PRESS RELEASE
The global leader for SEEG depth electrodes, resuming direct sales in the U.S. following the contractual end of its distribution partnership with NeuroPace.
CHAUDEFONTAINE, FRANCE, April 3, 2025 — By regaining control of direct sales, DIXI Medical will have greater operational flexibility for launching new technologies and maintaining its pricing policy for U.S customers. Indeed, this strategic move will allow DIXI Medical to restore its margins and ensure competitive prices for its customers.
“This strategic move allows us to better serve our customers and become more agile to deploy our next innovative technologies in response to market demands,” said Mark Lemko, CEO of DIXI Medical USA.
DIXI Medical will accelerate its development in a rapidly expanding market by deploying a dedicated sales team to provide focused clinical support. During the three-year distribution contract with NeuroPace, DIXI Medical maintained a team of experts to ensure the continuity of high-quality offerings. This experienced team will remain in place, ensuring that its customers experience no disruption in service and continue to receive the same exceptional support.
“We are excited to take this next step in our growth journey. Our strong team and unwavering commitment to quality will ensure a seamless transition for our customers,” said Frédéric Koehn, Chairman & CEO DIXI Medical Holding. ” We would also like to thank NeuroPace for the great cooperation we have had over the past three years.”
The company will continue investing in its educational program. Launched in 2022 and acclaimed by neurosurgeons and epileptologists, the SEEG courses have attracted over 400 clinicians, with the latest session being a resounding success. DIXI Medical’s investments in training foster close collaboration with physicians through comprehensive training programs, enhancing their expertise and ensuring the highest standards of patient care.
The global leader for SEEG depth electrodes, resuming direct sales in the U.S. following the contractual end of its distribution partnership with NeuroPace.
Epilepsy treatment has come a long way. For decades, clinicians relied on surface EEG and educated guesswork to determine the origins of seizures, often falling short when it came to localizing deep-seated seizure foci.
Neurosurgery is experiencing a transformative era, with intracerebral electrodes playing a pivotal role in advancing our understanding and treatment of neurological disorders, particularly epilepsy.
Faiçal Isbaine joined DIXI medical as our new Director Clinical Development
We are pleased to announce the creation of a new scientific direction within DIXI medical...
At DIXI medical, we are proud to support the continuing and specialized education of healthcare professionals in the field of epilepsy.
We are delighted to announce the arrival of our new VP Research & Development, Pierre Fridez.
We are thrilled to announce that Health Canada has approved thermocoagulation procedures as an extension of the intended use of our depth electrodes.
John Gale, renowned Neurophysiologist, Vice President of DIXI NeuroLab, launches an insightful 6-Episode webinar on the inner workings of the human brain and microelectrode recordings.
MEET KILLIAN PEIER! Killian Peier is a Swiss ski-jumping athlete, silver medallist at the World Championships in 2018. DIXI is proud to
PASSION AND DEDICATION In those uncertain times, some things remain unchanged… our passion and dedication!It might be ski jumping, or manufacturing intracerebral
A BIT OF FRESH AIR… We all love Summertime! ? But we also do like to have a short and refreshing break
EPILEPSYX.NET DIXI medical is very proud to support EpilepsyX.Net. This initiative is made by and for Doctors and Healthcare Professional Treating Epilepsy Care
NEW MEMS SEEG ELECTRODE Exciting news for the future of SEEG electrodes! Click on the link here: https://www.globenewswire.com/news-release/2021/07/06/2257955/0/en/Adept-Neuro-Reaches-Key-Milestone-in-the-Development-of-Novel-Intracerebral-Stereoelectroencephalography-SEEG-Electrodes.html Video template title Video
KILLIAN IS BACK IN THE AIR? Killian did his first jump since his injury! We are delighted to know him back in
EPILEPSY AWARENESS MONTH? November is Epilepsy Awareness Month. It is time to exchange, share information, and raise awareness together. Video template title Video
MICRODEEP® MICRO-MACRO DEPTH ELECTRODE We are very happy to announce that the MICRODEEP® Micro-Macro Electrode is now FDA cleared. A unique multi-contact, flexi-rigid
NEUROPACE ANNOUNCES DISTRIBUTION AGREEMENT WITH DIXI MEDICAL USA NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments